Skip to main content
. 2021 Mar 26;39(3):326–335. doi: 10.1002/hon.2861

FIGURE 1.

FIGURE 1

(A) Overall PFS, (B) PFS by ECOG ( p < 0.001), (C) PFS by IGHV status (p = 0.01), and (D) PFS by number of previous lines of therapy (p = 0.02). PFS, progression‐free survival